Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 8/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | PRKACA | P17612 | 1/20 | 0.39 |
| ▸ | PRKACG | P22612 | 1/20 | 0.39 |
| ▸ | PRKACB | P22694 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7502762 | 0.88 | MAOA (0.48) | PTGS2PTGS1 | |
| SCHEMBL7502853 | 0.87 | PTGS2 (0.44) | PTGS2PTGS1AKR1C2AKR1C1AKR1C3 | |
| SCHEMBL7498185 | 0.87 | PTGS2 (0.62) | PTGS2PTGS1ESR1AKR1C2AKR1C1 | |
| SCHEMBL7507139 | 0.86 | AKR1C2 (0.43) | PTGS2PTGS1AKR1C2AKR1C1AKR1C3 | |
| SCHEMBL7497620 | 0.84 | PTGS1 (0.55) | PTGS2PTGS1ESR1 | |
| SCHEMBL7499994 | 0.83 | PTGS2 (0.54) | PTGS2PTGS1ESR1AKR1C2AKR1C1 | |
| SCHEMBL7504055 | 0.81 | KAT6A (0.42) | PTGS2PTGS1AKR1C2AKR1C3 | |
| SCHEMBL7501526 | 0.80 | PTGS2 (0.51) | PTGS2PTGS1ESR1AKR1C2AKR1C1 | |
| SCHEMBL7498908 | 0.79 | PTGS2 (0.55) | PTGS2PTGS1ESR1AKR1C2AKR1C1 | |
| SCHEMBL7501533 | 0.79 | PTGS2 (0.50) | PTGS2PTGS1ESR1PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0966437-B1 | 5-AROYLNAPHTHALENE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2002-06-12 | — | — | EP | disclosed |
| US-6150397-A | 5-(PYRIDYL, FURYL, OR THIENYL SUBSTITUTED)-6-SUBSTITUTED-2--2-NAPHTHALENESULFONAMIDES OF GIVEN FORMULA; INHIBITORS OF PROSTAGLANDIN G/H SYNTHASE; TREATING INFLAMMATORY DISEASE SUCH AS GOUT, ARTHRITIS, MYOSITIS, SYNOVITIS | SYNTEX (U.S.A.) INC. (US) | 2000-11-21 | — | — | US | disclosed |
| EP-0966437-A1 | 5-AROYLNAPHTHALENE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 1999-12-29 | — | — | EP | disclosed |
| US-5962531-A | PROSTAGLANDIN SYNTHASE INHIBITOR; RHEUMATIC DISORDERS | SYNTEX (U.S.A.) INC. (US) | 1999-10-05 | — | — | US | disclosed |
| WO-1998032732-A1 | 5-AROYLNAPHTHALENE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1998-07-30 | — | — | WO | disclosed |